| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 6 775-785, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
S Fagerstrom, S Pahlman, C Gestblom and E Nanberg
Department of Pathology, University Hospital, Uppsala, Sweden.
A combination of basic fibroblast growth factor (bFGF) and insulin-like growth factor-I (IGF-I) or 16 nM 12-O-tetradecanoylphorbol-13-acetate (TPA) and serum induces human SH-SY5Y neuroblastoma cells to undergo differentiation and acquire a neuronal phenotype. Nerve growth factor (NGF) added to SH-SY5Y cells stably transfected with the NGF-receptor TRK-A (SH-SY5Y/trk) induces a similar differentiated phenotype. SH-SY5Y cells express protein kinase C (PKC)-alpha, PKC-beta I, PKC-epsilon, and PKC-zeta protein, and phorbol ester- or growth factor-induced differentiation results in a sustained activation of PKC. The specific PKC inhibitor GF 109203X blocked TPA- and bFGF-IGF-I-induced neurite outgrowth in wild-type SH-SY5Y cells and NGF-induced neurite outgrowth in SH-SY5Y/trk cells. When added to differentiated cells, GF 109203X caused rapid retraction of growth cone filopodia. In TPA- and bFGF-IGF-I-treated cells, addition of GF 109203X also blocked induced expression of growth associated protein-43 and neuropeptide tyrosine while the increase in expression of these two genes was only slightly affected by the inhibitor in NGF-treated SH-SY5Y/trk cells. Thus, a portion of the NGF-induced phenotypic changes appears not to be mediated via PKC-dependent signaling. A high concentration of TPA (1.6 microM) down regulated PKC-alpha and PKC-beta I almost completely and PKC-epsilon partially in wild-type SH-SY5Y and SH-SY5Y/trk cells. Cells with down-regulated PKC-alpha and PKC-beta I after 1.6 microM TPA treatment still differentiated with growth factors. In these cells, the PKC-epsilon level was restored, and the PKC-epsilon protein was enriched in the growth cones. The 1.6 microM TPA-induced down-regulation of PKC-epsilon was counteracted by bFGF and NGF but not by platelet-derived growth factor or IGF-I. These data indicate that PKC activity is vital for neurite formation, and that the cells can differentiate under conditions when PKC-alpha and PKC-beta I are extensively down regulated. The close correlation between differentiation and presence of PKC-epsilon protein suggests an important function for this isoform during this process.
This article has been cited by other articles:
![]() |
L. Sunesson, U. Hellman, and C. Larsson Protein Kinase C{epsilon} Binds Peripherin and Induces Its Aggregation, Which Is Accompanied by Apoptosis of Neuroblastoma Cells J. Biol. Chem., June 13, 2008; 283(24): 16653 - 16664. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gopalakrishna, U. Gundimeda, J. E. Schiffman, and T. H. McNeill A Direct Redox Regulation of Protein Kinase C Isoenzymes Mediates Oxidant-induced Neuritogenesis in PC12 Cells J. Biol. Chem., May 23, 2008; 283(21): 14430 - 14444. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Parran, A. Barker, and M. Ehrich Effects of Thimerosal on NGF Signal Transduction and Cell Death in Neuroblastoma Cells Toxicol. Sci., July 1, 2005; 86(1): 132 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ling, U. Troller, R. Zeidman, H. Stensman, A. Schultz, and C. Larsson Identification of Conserved Amino Acids N-terminal of the PKC{epsilon}C1b Domain Crucial for Protein Kinase C{epsilon}-mediated Induction of Neurite Outgrowth J. Biol. Chem., May 6, 2005; 280(18): 17910 - 17919. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mikule, S. Sunpaweravong, J. C. Gatlin, and K. H. Pfenninger Eicosanoid Activation of Protein Kinase C {epsilon}: INVOLVEMENT IN GROWTH CONE REPELLENT SIGNALING J. Biol. Chem., May 30, 2003; 278(23): 21168 - 21177. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gannon-Murakami and K. Murakami Selective Association of Protein Kinase C with 14-3-3 zeta in Neuronally Differentiated PC12 Cells. STIMULATORY AND INHIBITORY EFFECT OF 14-3-3 zeta IN VIVO J. Biol. Chem., June 21, 2002; 277(26): 23116 - 23122. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kabir, A. W. Schaefer, A. Nakhost, W. S. Sossin, and P. Forscher Protein Kinase C Activation Promotes Microtubule Advance in Neuronal Growth Cones by Increasing Average Microtubule Growth Lifetimes J. Cell Biol., March 5, 2001; 152(5): 1033 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zeidman, B. Lofgren, S. Pahlman, and C. Larsson PKCepsilon , Via its Regulatory Domain and Independently of its Catalytic Domain, Induces Neurite-like Processes in Neuroblastoma Cells J. Cell Biol., May 17, 1999; 145(4): 713 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brodie, K. Bogi, P. Acs, P. Lazarovici, G. Petrovics, W. B. Anderson, and P. M. Blumberg Protein Kinase C-{{epsilon}} Plays a Role in Neurite Outgrowth in Response to Epidermal Growth Factor and Nerve Growth Factor in PC12 Cells Cell Growth Differ., March 1, 1999; 10(3): 183 - 191. [Abstract] [Full Text] |
||||
![]() |
R. Prekeris, R. M. Hernandez, M. W. Mayhew, M. K. White, and D. M. Terrian Molecular Analysis of the Interactions between Protein Kinase C-epsilon and Filamentous Actin J. Biol. Chem., October 9, 1998; 273(41): 26790 - 26798. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fagerstrom, S. Pahlman, and E. Nanberg Protein Kinase C-dependent Tyrosine Phosphorylation of p130cas in Differentiating Neuroblastoma Cells J. Biol. Chem., January 23, 1998; 273(4): 2336 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zeidman, U. Troller, A. Raghunath, S. Pahlman, and C. Larsson Protein Kinase Cepsilon Actin-binding Site Is Important for Neurite Outgrowth during Neuronal Differentiation Mol. Biol. Cell, January 1, 2002; 13(1): 12 - 24. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |